Articles tagged "Donation"

2018 American Transplant Congress
APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO)
G. Guerra,¹ E. Poggio,² M. Ortigosa-Goggins,¹ M. Doshi,³ B. Freedman,⁴ D. Reboussin,⁴ P. Kimmel,⁵ APOLLO Investigators.
¹Miami Transplant Institute, Miami, FL; ²Cleveland Clinic, Cleveland, OH; ³University of Michigan, Ann Arbor, MI; ⁴Wake Forest School of Medicine, Winston-Salem, NC; ⁵NIDDK, Bethesda, MD.
Two renal-risk variants in the apolipoprotein L1 gene (APOL1) are powerfully associated with a spectrum of non-diabetic chronic kidney diseases in populations with recent African…
2018 American Transplant Congress
A Medical Decision Analysis for the Use of Donation after Cardiac Death Donors for Simultaneous Liver-Kidney Transplant
A. Miller, K. Tennankore, B. Kiberd.
Division of Nephrology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
For patients on the simultaneous liver-kidney transplant (SLKT) waitlist, acceptance of donation after cardiac death (DCD) organs may facilitate earlier transplantation thereby reducing waitlist mortality,…
2018 American Transplant Congress
Accepting a DCD Liver May Improve Patient Survival Compared to Waiting for a Non-DCD Liver
A. Wey,¹ N. Salkowski,¹ J. Lake,² W. Kim,³ B. Kasiske,¹ A. Israni,¹ J. Snyder.¹
¹Scientific Registry of Transplant Recipients, Minneapolis; ²Univ of Minnesota, Minneapolis; ³Stanford University, Palo Alto.
Only ~50% of liver candidates undergo deceased donor transplant; 17% die on the waiting list and 20% are removed from the list as too sick…
2018 American Transplant Congress
Meeting OPTN Requirements for Living Kidney Donation Follow-Up: Findings from the KDOC Study
J. Rodrigue,¹ C. Sokas,¹ A. Fleishman,¹ J. Schold,² P. Morrissey,³ J. Whiting,⁴ J. Vella,⁴ L. Kayler,⁵ D. Katz,⁶ J. Jones,⁶ B. Kaplan,⁷ M. Pavlakis,¹ D. Mandelbrot.⁸
¹Beth Israel Deaconess Medical Center, Boston; ²Cleveland Clinic, Cleveland; ³Rhode Island Hospital, Providence; ⁴Maine Medical Center, Portland; ⁵Erie County Medical Center, Buffalo; ⁶University of Iowa, Iowa City; ⁷Mayo Clinic, Scottsdale; ⁸University of Wisconsin, Madison.
The Organ Procurement and Transplantation Network (OPTN) requires programs to submit complete, accurate and timely clinical information for 80% and laboratory data for 70% of…
2018 American Transplant Congress
Survival Advantage from Accepting a Circulatory Death Liver Transplant
J. Richards,¹ R. Taylor,² E. Allen,² A. Goh,¹ J. Neuberger,³ D. Collett,² G. Pettigrew.¹
¹Department of Surgery, University of Cambridge, Cambridge, United Kingdom; ²Statistics and Clinical Studies, NHS Blood and Transplant, Bristol, United Kingdom; ³Department of Medicine, University of Birmingham, Birmingham, United Kingdom.
Background As liver failure increases in the UK, so does demand for liver transplantation. In response, UK donation after circulatory death (DCD) activity has approximately…
2018 American Transplant Congress
Implementing Mobile Health Technology for Living Kidney Donor Follow-Up: Transplant Provider Perspectives
A. Eno,¹ J. Ruck,¹ S. Rasmussen,¹ D. Segev,^1,2 M. Henderson.¹
¹Department of Surgery, Johns Hopkins School of Medicine, Baltimore; ²Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore.
Transplant hospitals are required to collect and report living kidney donor (LKD) follow-up data at 6-months, 1-year, and 2-years, but fewer than 50% of hospitals…
2018 American Transplant Congress
Delayed Recovery of Renal Function after Donor Nephrectomy
J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
¹Department of Urology, Yonsei University College of Medicine, Urological Science Institute, Seoul, Korea; ²Department of Urology, National Health Insurance Service Ilsan Hospital, Goyang-si, Korea; ³Department of Urology, Hanyang University Medical Center, Seoul, Korea; ⁴Department of Surgery-Transplantation, Yonsei University College of Medicine, Seoul, Korea.
Introduction:Among living kidney donors at risk of CKD at 1 year after nephrectomy, some donors remain with poor renal function while many show delayed recovery…
2018 American Transplant Congress
Ex-Vivo Subnormothermic Oxygenated Machine Perfusion of Rodent Hindlimb: Feasibility Study to Elongate Preservation Time of Vascularized Composite Allograft
L. Burlage,^1,2 A. Lellouch,^3,4 S. Tessier,¹ C. Pendexter,¹ S. Cronin,¹ M. Schol,³ M. Randolph,³ R. Porte,² L. Lantieri,⁴ C. Cetrulo,³ K. Uygun.¹
¹Surgery, Massachusetts General Hospital/Harvard Medical School, Boston; ²Surgery, University Medical Center Groningen, Groningen, Netherlands; ³Plastic Surgery, Massachusetts General Hospital/Harvard Medical School, Boston; ⁴Plastic Surgery, European George Pompidou Hospital, Paris, France.
PURPOSE: A pressing challenge in the field of VCA is adequate tissue preservation. Static cold preservation, successfully used in field of solid organ transplantation, greatly…
2018 American Transplant Congress
Temporal Trends in Living Kidney Donor Candidates
S. Singh,^1,2 V. DiCecco,² M. Luo,² Y. Li,² O. Famure.²
¹Division of Nephrology, Department of Medicine, University of Toronto, Toronto, ON, Canada; ²Division of Nephrology and the Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
Living kidney donor transplantation is the preferred treatment option for end-stage renal disease. However, living kidney donation rates have plateaued in North America. Existing studies…
2018 American Transplant Congress
Impact of Glomerular Filtration Rate Normalization to Body Surface Area on Donor Selection and Outcome in over 4000 Living Kidney Donors
S. Riad,¹ D. Keys,¹ D. Vock,¹ S. Jackson,¹ D. Berglund,¹ V. Vakil,¹ A. Matas,¹ H. Ibrahim.³
¹U of MN, Minneapolis; ²Houston Methodist, Houston.
Introduction: A donor GFR of ≥ 80 mL/min is a selection criterion. KDIGO recommends that GFR indexed to BSA should be used. Herein, we tested…